RLAY vs RYTM Stock Comparison
RYTM currently leads RLAY in this stock comparison, with AIQ scores of 62 vs 56. The clearest difference is value, while RLAY has the stronger momentum profile.
What is the main difference between RLAY and RYTM?
RYTM leads the current stock comparison as Rhythm Pharmaceuticals, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Relay Therapeutics, Inc. vs Rhythm Pharmaceuticals, Inc.
RYTM leads
RYTM leads by 6 AIQ points, primarily on Value and Quality. Wall Street currently favors RLAY on target upside.
Competitive: 4 of 6 evidence groups support RYTM, and its current signal state is conflicted.
Relay Therapeutics, Inc.
Rhythm Pharmaceuticals, Inc.
The Algovestiq AIQ Score currently favors RYTM over RLAY, 62 versus 56 as of Nov 15, 2026. RYTM's advantage is driven primarily by stronger value and quality, while RLAY holds the stronger momentum profile. RYTM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors RLAY. 4 of 6 covered evidence groups favor RYTM today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. RYTM lead: Stable — the AIQ differential has held near 6 points over 30 sessions.
Compare Relay Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare RLAY and RYTM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value37 vs 52RYTM +15
- Quality47 vs 60RYTM +13
- Risk Resilience52 vs 57RYTM +5
- Momentum76 vs 72RLAY +4
4 of 6 evidence groups favor RYTM. RYTM’s edge is concentrated in value and quality; RLAY keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +2
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.58x)
Largest factor move: Momentum +4
New signals
- ADX Trend Strengthening — neutral, trend, medium horizon
RYTM's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — RLAY and RYTM both carry a full feed there.
The central trade-off
RYTM (Rhythm Pharmaceuticals, Inc.): the stronger current systematic profile, led by value and quality.
RLAY (Relay Therapeutics, Inc.): the counter-case, on momentum, fundamentals, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
RYTMRYTM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
RYTMRYTM on combined revenue and EPS growth.
Value
RYTMRYTM on the peer-relative Value factor, by 15 points.
Momentum
RLAYRLAY on the Momentum factor, by 4 points.
Lower downside
RYTMRYTM on Risk Resilience, by 5 points.
Analyst upside
RLAYRLAY on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors RYTM, analyst targets favor RLAY. That disagreement is the most useful thing on this page.
| Measure | RLAY | RYTM | Note |
|---|---|---|---|
| Implied upside to target | +60.3% | +18.5% | RLAY has more room |
| Target dispersion | 0% | +28.6% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 13 | 19 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor RYTM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | RYTM | 56 vs 62 |
| Fundamentals | RLAYon balance | revenue growth -100% vs 29.3%; EPS growth 9.8% vs 16.4%; TTM ROE -10% vs -20.5%; gross margin 89.3% vs 88.2%; operating margin -30.9% vs -66.7% — RLAY takes 3 of 5 decided legs, not all of them |
| Valuation | RYTM | Value 37 vs 52 |
| Technicals | RYTM | Price vs 50-day -1.5% vs 18.7%; vs 200-day 16.4% vs 18.3% |
| Risk Resilience | RYTM | Risk Resilience 52 vs 57 |
| Analyst expectations | RLAY | Target upside 60.3% vs 18.5% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of RLAY and RYTM and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 6 points.
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on RYTM.
How the comparison changed
120 daily snapshots · May 27 – Nov 13RYTM lead: Stable — the AIQ differential has held near 6 points over 30 sessions.
- Today
- RYTM +6
- 56 vs 62
- 7 sessions ago
- RYTM +2
- 55 vs 57
- 30 sessions ago
- RYTM +6
- 49 vs 55
- 90 sessions ago
- RYTM +2
- 60 vs 62
The lead changed hands 3 times in this window, most recently on Nov 6 when RYTM moved ahead of RLAY.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 2 bearish / 2 neutral, conflicted
Only RLAY
- Golden Cross Active — bullish, trend, long horizon (18.25%)
- ADX Trend Weakening — neutral, trend, medium horizon
3 bullish / 3 bearish / 2 neutral, conflicted
Only RYTM
- Death Cross Active — bearish, trend, long horizon (0.37%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
Both carry 5 more signals that do not separate them: ATR Expansion - Breakout Mode, Beta Spike Warning, EMA Ribbon Expansion Bullish, Low Volume Rally Warning, TRIX Bullish Signal.
RYTM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.06%, AIQ +1 points).
Price and the AIQ Score both moved up over the latest session (price +4.7%, AIQ +2 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1RLAY closes the Value gap — currently 15 points behind, the largest single contributor to RYTM's edge.
- 2RLAY's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
- 3RYTM's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
RLAY leads on balance| Metric | RLAY | RYTM |
|---|---|---|
| Revenue growth (YoY) | -100% | 29.3% |
| EPS growth (YoY) | 9.8% | 16.4% |
| Gross margin | 89.3% | 88.2% |
| Operating margin | -30.9% | -66.7% |
| Return on equity (TTM) | -10% | -20.5% |
| Debt to equity | 0.03 | 0.02 |
Performance
Split across windows| Metric | RLAY | RYTM |
|---|---|---|
| 1 week (5 sessions) | -2.7% | 2.4% |
| 1 month (20 sessions) | 11.1% | 33.5% |
| 3 months (63 sessions) | -12.5% | -0.4% |
| 6 months (126 sessions) | 48.3% | 27.1% |
| Year to date | 113.8% | 7.5% |
| 1 year (252 sessions) | 193.2% | 17.5% |
Technicals
RYTM has the stronger structure| Metric | RLAY | RYTM |
|---|---|---|
| RSI (14) | 47.9 | 66.3 |
| ADX (14) | 14.3 | 28.5 |
| Price vs 50-day | -1.5% | 18.7% |
| Price vs 200-day | 16.4% | 18.3% |
| Volatility (1M, annualized) | 80.3% | 110.9% |
Risk
RYTM is the more resilient| Metric | RLAY | RYTM |
|---|---|---|
| Beta | 1.66 | 1.24 |
| Sharpe ratio | 1.84 | 0.52 |
| Sortino ratio | 3.13 | 0.89 |
| Max drawdown | -28.2% | -35.5% |
| Current drawdown | -12.8% | -2.2% |
| Annualized volatility | 65.8% | 54.6% |
| Value at risk (95%) | -5.4% | -5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, RLAY or RYTM?
On the Algovestiq AIQ Score, RYTM is the stronger of the two as of Nov 15, 2026, scoring 62 against RLAY's 56. The edge comes from value and quality. RLAY is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is RLAY or RYTM the better buy right now?
RYTM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor RYTM over RLAY?
The composite weights Quality, Value, Momentum and Risk Resilience. RYTM leads Value by 15 points; RYTM leads Quality by 13 points; RYTM leads Risk Resilience by 5 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, RLAY or RYTM?
Analyst price targets imply +60.3% upside for RLAY and +18.5% for RYTM, so the Street currently favors RLAY. That points the opposite way to the AIQ Score, which favors RYTM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, RLAY or RYTM?
RYTM is the better-valued of the two on the peer-relative Value factor. RYTM on the peer-relative Value factor, by 15 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, RLAY or RYTM?
RYTM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, RLAY or RYTM?
RLAY on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, RLAY or RYTM?
RYTM is the more resilient of the two, so the other name carries the higher downside risk. RYTM on Risk Resilience, by 5 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is RLAY more profitable than RYTM?
RLAY leads on the comparable margin measures — gross margin 89.3% vs 88.2%; operating margin -30.9% vs -66.7%; ttm roe -10% vs -20.5%.
Is RYTM's lead over RLAY getting stronger or weaker?
RYTM lead: Stable — the AIQ differential has held near 6 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-11-06, when RYTM moved ahead of RLAY.
What would change the RLAY vs RYTM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RLAY closes the Value gap — currently 15 points behind, the largest single contributor to RYTM's edge; RLAY's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; RYTM's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about RLAY and RYTM?
RLAY: 3 bullish / 2 bearish / 2 neutral, conflicted. RYTM: 3 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on RLAY is Golden Cross Active (bullish, long horizon). On RYTM it is Death Cross Active (bearish, long horizon).
Compare RLAY and RYTM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.